Bertram Pitt in conversation with Frank Ruschitzka
PEARL HF: Multicentre, randomized, double-blind, placebo-controlled, parallel-group, mulitple-dose study to evaluate the effects of RLY5016 in heart failure patients.
Michael Komajda in conversation with Frank Ruschitzka
SHIFT: Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction.
This webinar was presented on Thursday, September 23, 2010 by Dr. Larisa Cavallari and Dr. Jaekyu Shin. Dr. Cavallari and Dr. Shin discuss select pharmacogenomic effects of clopidogrel and beta blockers.